MONDAY, June 30, 2025 -- For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the...
Vous n'êtes pas connecté
Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […]
MONDAY, June 30, 2025 -- For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the...
FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild...
Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia...
"Autism Spectrum Disorder Clinical Trials" Autism spectrum disorder companies, such as Astrogen, MapLight Therapeutics, Axial Therapeutics, Aardvark...
"Autism Spectrum Disorder Clinical Trials" Autism spectrum disorder companies, such as Astrogen, MapLight Therapeutics, Axial Therapeutics, Aardvark...
Dr. Peter V. Rabins has been studying the brain, and dementia in particular, for a half century, since before most Americans had heard of Alzheimer...
Teclistamab shows promising results in high-risk multiple myeloma patients, including those ineligible for trials due to previous therapies.
The article explores how Christian counselors address the unique challenges of dementia and Alzheimer’s, integrating biblical truths with...
A new study reveals that learning about one’s risk for Alzheimer’s disease doesn’t cause emotional harm—but even those at high risk often lose...
Evening habits influence brain health. Alzheimer's disease is a major concern. Avoid heavy meals before bed for better sleep. Sugary drinks increase...